More on SRPT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (4.4 Score)
- Holders
- FDA Archive

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Sarepta Therapeutics (NQ:SRPT)
Delayed: 18.82 -0.13 (0.69%)
Prev. Close $18.95  
Open$18.97 
52 Wk High$63.73 
52 Wk Low$8.00 
Day High$19.36 
Day Low$18.52 
P/E N/A  
EPS$-5.69 
Volume2,457,720 

Friends, Peers and Foes (?): ARWR, BBT, BHLB, BRKL, ELAN (more...)

Jul 9, 2026 07:11 AM Sarepta Therapeutics (SRPT) PT Lowered to $20 at Piper Sandler
Jul 8, 2026 05:07 PM Wolfe Research Upgrades Sarepta Therapeutics (SRPT) to Outperform
Jul 1, 2026 06:58 AM H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
Jun 30, 2026 04:25 PM Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 30, 2026 11:00 AM Mizuho Reiterates Outperform Rating on Sarepta Therapeutics (SRPT)
Jun 30, 2026 08:30 AM FDA accepts Sarepta's applications to convert two DMD drugs to full approval
Jun 30, 2026 08:30 AM Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
Jun 18, 2026 06:11 AM Sarepta Therapeutics (SRPT) 5700 contracts of July 20 calls trade
Jun 5, 2026 08:11 PM Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Boor Kathryn Jean
Jun 5, 2026 08:10 PM Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Mayo Stephen
View All Articles

Entities mentioned with SRPT

View All Entities